Literature DB >> 15182896

Network therapy: decreased secondary opioid use during buprenorphine maintenance.

Marc Galanter1, Helen Dermatis, Linda Glickman, Robert Maslansky, M Brealyn Sellers, Erna Neumann, Claudia Rahman-Dujarric.   

Abstract

Network therapy (NT) employs family members and/or friends to support compliance with an addiction treatment carried out in office practice. This study was designed to ascertain whether NT is a useful psychosocial adjunct, relative to a control treatment, for achieving diminished illicit heroin use for patients on buprenorphine maintenance. Patients agreeing to randomization to either NT (N = 33) or medication management (MM, N = 33) were inducted onto short-term buprenorphine maintenance and then tapered to zero dose. NT resulted in significantly more urine toxicologies negative for opioids than MM (65% vs. 45%) and more NT than MM patients (50% vs. 23%) experienced a positive outcome relative to secondary heroin use by the end of treatment. The use of NT in office practice may therefore improve the effectiveness of eliminating secondary heroin use during buprenorphine maintenance. It may also be useful in enhancing compliance with an addiction treatment regimen in other contexts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15182896     DOI: 10.1016/j.jsat.2004.03.002

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  10 in total

Review 1.  Hepatitis infection in the treatment of opioid dependence and abuse.

Authors:  Thomas F Kresina; Diana Sylvestre; Leonard Seeff; Alain H Litwin; Kenneth Hoffman; Robert Lubran; H Westley Clark
Journal:  Subst Abuse       Date:  2008-04-28

Review 2.  Antagonist Models for Relapse Prevention and Reducing HIV Risk.

Authors:  George E Woody; Evgeny Krupitsky; Edwin Zvartau
Journal:  J Neuroimmune Pharmacol       Date:  2016-02-27       Impact factor: 4.147

3.  Physicians' Decision-making When Implementing Buprenorphine With New Patients: Conjoint Analyses of Data From a Cohort of Current Prescribers.

Authors:  Hannah K Knudsen; Michelle R Lofwall; Sharon L Walsh; Jennifer R Havens; Jamie L Studts
Journal:  J Addict Med       Date:  2018 Jan/Feb       Impact factor: 3.702

4.  Intimate Strangers? Social Networks in HIV Prevention Groups for Drug Users.

Authors:  Thomas Lyons; Krystal Madkins; Pritesh Karia; Grady Garner
Journal:  J Groups Addict Recover       Date:  2013-04-01

Review 5.  Buprenorphine Treatment for Opioid Use Disorder: An Overview.

Authors:  Matisyahu Shulman; Jonathan M Wai; Edward V Nunes
Journal:  CNS Drugs       Date:  2019-06       Impact factor: 5.749

Review 6.  Social networks and neurological illness.

Authors:  Amar Dhand; Douglas A Luke; Catherine E Lang; Jin-Moo Lee
Journal:  Nat Rev Neurol       Date:  2016-09-12       Impact factor: 42.937

Review 7.  A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world.

Authors:  Michelle R Lofwall; Sharon L Walsh
Journal:  J Addict Med       Date:  2014 Sep-Oct       Impact factor: 3.702

8.  Adjunct interventions to standard medical management of buprenorphine in outpatient settings: A systematic review of the evidence.

Authors:  Jessica J Wyse; Benjamin J Morasco; Jacob Dougherty; Beau Edwards; Devan Kansagara; Adam J Gordon; P Todd Korthuis; Anaïs Tuepker; Stephan Lindner; Katherine Mackey; Beth Williams; Anders Herreid-O'Neill; Robin Paynter; Travis I Lovejoy
Journal:  Drug Alcohol Depend       Date:  2021-07-29       Impact factor: 4.852

9.  Treating homeless opioid dependent patients with buprenorphine in an office-based setting.

Authors:  Daniel P Alford; Colleen T LaBelle; Jessica M Richardson; James J O'Connell; Carole A Hohl; Debbie M Cheng; Jeffrey H Samet
Journal:  J Gen Intern Med       Date:  2007-02       Impact factor: 5.128

10.  Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial.

Authors:  Marc Fishman; Kevin Wenzel; Jennifer Scodes; Martina Pavlicova; Aimee N C Campbell; John Rotrosen; Edward Nunes
Journal:  Am J Addict       Date:  2021-06-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.